Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 10, 2010, Pages 4107-4111

  Nakaminami, Hidemasa ^a   Noguchi, Norihisa ^a   Sasatsu, Masanori ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; MULTIDRUG BINDING PROTEIN QACA; MULTIDRUG BINDING PROTEIN QACB; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN VARIANT; SITE DIRECTED MUTAGENESIS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MEMBRANE TRANSPORT PROTEINS; PLASMIDS; STAPHYLOCOCCUS AUREUS;

EID: 77957333809     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01065-09     Document Type: Article

References (28)

1. Alam, M. M., N. Kobayashi, N. Uehara, and N. Watanabe. 2003. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 9:109-121.
2. Asuquo, A. E., and L. J. Piddock. 1993. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 31:865-880.
3. CLSI. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Grkovic, S., M. H. Brown, K. M. Hardie, N. Firth, and R. A. Skurray. 2003. Stable low-copy-number Staphylococcus aureus shuttle vectors. Microbiology 149:785-794.
5. Hassan, K. A., M. Galea, J. Wu, B. A. Mitchell, R. A. Skurray, and M. H. Brown. 2006. Functional effects of intramembranous proline substitutions in the staphylococcal multidrug transporter QacA. FEMS Microbiol. Lett. 263:76-85.
6. Hassan, K. A., R. A. Skurray, and M. H. Brown. 2007. Transmembrane helix 12 of the Staphylococcus aureus multidrug transporter QacA lines the bivalent cationic drug binding pocket. J. Bacteriol. 189:9131-9134.
7. Hassan, K. A., T. Souhani, R. A. Skurray, and M. H. Brown. 2008. Analysis of tryptophan residues in the staphylococcal multidrug transporter QacA reveals long-distance functional associations of residues on opposite sides of the membrane. J. Bacteriol. 190:2441-2449.
8. Littlejohn, T. G., I. T. Paulsen, M. T. Gillespie, J. M. Tennent, M. Midgley, I. G. Jones, A. S. Purewal, and R. A. Skurray. 1992. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 74:259-265.
9. Mayer, S., M. Boos, A. Beyer, A. C. Fluit, and F. J. Schmitz. 2001. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 47:896-897.
10. McDonnell, G., and A. D. Russell. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179.
11. Mitchell, B. A., M. H. Brown, and R. A. Skurray. 1998. QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones. Antimicrob. Agents Chemother. 42:475-477.
12. Mitchell, B. A., I. T. Paulsen, M. H. Brown, and R. A. Skurray. 1999. Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem. 274:3541-3548.
13. Nakaminami, H., N. Noguchi, S. Nishijima, I. Kurokawa, and M. Sasatsu. 2008. Characterization of the plasmid pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus. Plasmid 60:108-117.
14. Nakaminami, H., N. Noguchi, S. Nishijima, I. Kurokawa, H. So, and M. Sasatsu. 2007. Transduction of the plasmid encoding antiseptic resistance gene qacB in Staphylococcus aureus. Biol. Pharm. Bull. 30:1412-1415.
15. Noguchi, N., M. Hase, M. Kitta, M. Sasatsu, K. Deguchi, and M. Kono. 1999. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 172:247-253. (Pubitemid 29114955)
16. Noguchi, N., H. Nakaminami, S. Nishijima, I. Kurokawa, H. So, and M. Sasatsu. 2006. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J. Clin. Microbiol. 44:2119-2125.
17. Noguchi, N., J. Suwa, K. Narui, M. Sasatsu, T. Ito, K. Hiramatsu, and J. H. Song. 2005. Susceptibilities to antiseptic agents and distribution of antiseptic- resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999. J. Med. Microbiol. 54:557-565.
18. Noguchi, N., K. Takada, J. Katayama, A. Emura, and M. Sasatsu. 2000. Regulation of transcription of the mph(A) gene for macrolide 2′-phosphotransferase I in Escherichia coli: characterization of the regulatory gene mphR(A). J. Bacteriol. 182:5052-5058.
19. Paulsen, I. T., M. H. Brown, T. G. Littlejohn, B. A. Mitchell, and R. A. Skurray. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. U. S. A. 93:3630-3635.
20. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1998. Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system. J. Bacteriol. 180:3477-3479.
21. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
22. Piddock, L. J., Y. F. Jin, and D. J. Griggs. 2001. Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus. J. Antimicrob. Chemother. 47:261-270.
23. Rouch, D. A., D. S. Cram, D. DiBerardino, T. G. Littlejohn, and R. A. Skurray. 1990. Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Mol. Microbiol. 4:2051-2062.
24. Schmitz, F. J., A. C. Fluit, M. Luckefahr, B. Engler, B. Hofmann, J. Verhoef, H. P. Heinz, U. Hadding, and M. E. Jones. 1998. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 42:807-810.
25. Xu, Z., B. A. O'Rourke, R. A. Skurray, and M. H. Brown. 2006. Role of transmembrane segment 10 in efflux mediated by the staphylococcal multidrug transport protein QacA. J. Biol. Chem. 281:792-799.
26. Yamada, H., S. Kurose-Hamada, Y. Fukuda, J. Mitsuyama, M. Takahata, S. Minami, Y. Watanabe, and H. Narita. 1997. Quinolone susceptibility of norA-disrupted Staphylococcus aureus. Antimicrob. Agents Chemother. 41:2308-2309.
27. Yamane, K., J. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.
28. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.